==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 27
ID1032ThPPIDTh1006NameBivalirudinPeptide SequenceFPRPGGGGNGDFEEIPEEYL Full viewLength20Functional ClassificationIaDiseaseHematological,MetabolicBrandAngiomaxCompanyMedicines Co or MDCOPhysical AppearanceWhite lyophilized cake in single-use vialsRoute of AdministartionIntravenous infusionCategoryAntithrombins TargetProthrombin
ID1033ThPPIDTh1006NameBivalirudinPeptide SequenceFPRPGGGGNGDFEEIPEEYL Full viewLength20Functional ClassificationIaDiseaseHematological,MetabolicBrandAngioxCompanyThe Medicines Company UK LtdPhysical AppearancePowder for concentrate for solutionRoute of AdministartionInjectionCategoryAntithrombins TargetProthrombin
ID1038ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandEligardCompanyAtrix Labs/QLT InPhysical AppearanceSuspensionRoute of AdministartionSubcutaneous InjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1039ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandEnantoneCompanyTakedaPhysical AppearanceSolutionRoute of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1040ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeuplinCompanyTakedaPhysical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1041ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeuProMaxxCompanyBaxter/TevaPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1042ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeupromerCompanyN.A.Physical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1043ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLupronCompanyAbbott/TAP PharmaceuticalsPhysical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1044ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLutrateCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1045ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandMemryteCompanyCuraxisPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1046ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandProstap 3CompanyTakeda UK LimitedPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1047ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandProstap SRCompanyTakeda UK LimitedPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1048ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandViadurCompanyBayer AGPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1129ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecreFloCompanyRepligen CorpPhysical AppearanceLyophilized white powderRoute of AdministartionIntravenous infusionCategoryDiagnostic Agents TargetSecretin receptor
ID1130ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecremaxCompanyRepligen CorpPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryDiagnostic Agents TargetSecretin receptor
ID1187ThPPIDTh1024NameGramicidin DPeptide SequenceVGALAVVVWLWLWLWX Full viewLength16Functional ClassificationIIaDiseaseInfectiousBrandNeosporinCompanyPfizerPhysical AppearanceOintmentRoute of AdministartionExternal use onlyCategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic TargetN.A.
ID1188ThPPIDTh1024NameGramicidin DPeptide SequenceVGALAVVVWLWLWLWX Full viewLength16Functional ClassificationIIaDiseaseInfectiousBrandSofradexCompanySanofiPhysical AppearanceSterile, clear, bright, colourless, aqueous solutionRoute of AdministartionAuricular and Ocular use.CategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic TargetN.A.
ID1252ThPPIDTh1035NameGlucagon recombinantPeptide SequenceHSQGTFTSDYSKYLDSRRAQ Full viewLength29Functional ClassificationIVDiseaseHormonal/Metabolic/geneticBrandGlucaGenCompanyNovo NordiskPhysical AppearanceSterile, lyophilized white powderRoute of AdministartionSubcutaneous, Intramuscular, or Intravenous infusionCategoryHypoglycemic Agents TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1253ThPPIDTh1035NameGlucagon recombinantPeptide SequenceHSQGTFTSDYSKYLDSRRAQ Full viewLength29Functional ClassificationIVDiseaseHormonal/Metabolic/geneticBrandGlucagonCompanyEli LillyPhysical AppearancePowderRoute of AdministartionSubcutaneously or Intramuscularly InjectionCategoryHypoglycemic Agents TargetGlucagon receptor,Glucagon-like peptide 2 receptor,Glucagon-like peptide 1 receptor
ID1363ThPPIDTh1052NameEptifibatidePeptide SequenceMpr-Har-Gly-Asp-Trp- Full viewLength7Functional ClassificationIbDiseaseHematological/MetabolicBrandINTEGRILINCompanySchering-Plough/EssexPhysical AppearanceClear, colorless, sterile, non-pyrogenic solution  of EptifibatideRoute of AdministartionInjection Solution for IIntravenousUseCategoryPlatelet Aggregation Inhibitors TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1375ThPPIDTh1056NameVasopressinPeptide SequenceCYFQNCPRG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitressinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, aqueous solution of synthetic vasopressinRoute of AdministartionIntramuscular or Subcutaneous useCategoryAntidiuretic Agents TargetVasopressin V2 receptor,Vasopressin V1a receptor,Vasopressin V1b receptor
ID1460ThPPIDTh1087NameOxytocinPeptide SequenceCYIQNCPLG
Full view
Length9Functional ClassificationIbDiseaseHormonalBrandPitocinCompanyJHP PharmaceuticalsPhysical AppearanceSterile, clear, colorless aqueous solution of synthetic oxytocinRoute of AdministartionIntravenous infusionCategoryOxytocics, Anti-tocolytic Agents and Labor Induction Agents TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Globotriaosylceramide
ID1500ThPPIDTh1103NameCosyntropinPeptide SequenceACTH(1-24):
SYSM Full view
Length24Functional ClassificationIVDiseaseHormonalBrandCortrosynCompanyAmphastar PharmaceuticalsPhysical AppearanceN.A.Route of AdministartionIntravenous injection, Intravenous infusion, Intramuscular injectionCategoryHormones and Diagnostic Agents TargetAdrenocorticotropic hormone receptor
ID1531ThPPIDTh1110NameThymalfasinPeptide SequenceSDAAVDTSSEITTKDLKEKK Full viewLength28Functional ClassificationIbDiseaseInfectious/ImmunologicalBrandZadaxinCompanySciClone Pharmaceuticals (SCLN)Physical AppearanceN.A.Route of AdministartionSubcutaneous injectionCategoryN.A. TargetN.A.
ID1601ThPPIDTh1127NameBuserelinPeptide SequencepGlu-His-Trp-Ser-Tyr Full viewLength9Functional ClassificationIIIcDiseaseCancer/HormonalBrandSuprecur (injection)CompanySanofi-AventisPhysical Appearance1mg/ml InjectionRoute of AdministartionSubcutaneous injectionCategoryN.A. TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1641ThPPIDTh1146NameLucinactantPeptide SequenceKLLLLKLLLLKLLLLKLLLL Full viewLength21Functional ClassificationIbDiseaseGeneticBrandSurfaxinCompanyDiscovery Laboratories, Inc.Physical AppearanceSuspensionRoute of AdministartionIntratracheal administrationCategoryPulmonary surfactants TargetN.A.
ID1666ThPPIDTh1157NameSermorelinPeptide SequenceYADAIFTNSYRKVLGQLSAR Full viewLength30Functional ClassificationIaDiseaseHormonalBrandSermorelin acetateCompanyEmd serono incPhysical AppearanceSterile, non-pyrogenic, lyophilized powderRoute of AdministartionSubcutaneous InjectionCategoryHormone Replacement Agents TargetGrowth hormone-releasing hormone receptor